A detailed history of Omers Administration Corp transactions in Neurocrine Biosciences Inc stock. As of the latest transaction made, Omers Administration Corp holds 3,420 shares of NBIX stock, worth $468,027. This represents 0.0% of its overall portfolio holdings.

Number of Shares
3,420
Previous 6,120 44.12%
Holding current value
$468,027
Previous $842,000 53.33%
% of portfolio
0.0%
Previous 0.01%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$114.58 - $153.15 $309,366 - $413,505
-2,700 Reduced 44.12%
3,420 $393,000
Q2 2024

Aug 13, 2024

BUY
$130.86 - $143.19 $800,863 - $876,322
6,120 New
6,120 $842,000

Others Institutions Holding NBIX

About NEUROCRINE BIOSCIENCES INC


  • Ticker NBIX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 95,639,296
  • Market Cap $13.1B
  • Description
  • Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...
More about NBIX
Track This Portfolio

Track Omers Administration Corp Portfolio

Follow Omers Administration Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Omers Administration Corp, based on Form 13F filings with the SEC.

News

Stay updated on Omers Administration Corp with notifications on news.